Epstein Secrets

Mellon-Pitt Corp. Charlie Kim - CEO, Next)ump. David Kirkpatrick - Author, The Facebook Effect. Fmr head technolog

dan vs. Rumsfeld. Terry Kawaja - CEO, Luma Partners. Juliette Kayyem - Foreign Affairs Columnist, Boston Globe. Lecturer in Public Policy, Harvard. Asst Sec. for Intergovernmental Affairs, U.S. Dept. of Homeland Security. Jeff Kearl - Chm, SkullCandy. Peter Kellner - MD, Richmond Management. Cofounder,

Carnegie Mellon.Boards: Quantpoint, BioMatricore, BitArmor, Children's Institute, IIT Foundation, Mellon-Pitt Corp. *Charlie Kim'- CEO, NextJump. *David Kirkpatrick*- Author, /The Facebook Effect/. Fmr head technology writer, FORTUNE. *Henry Kravis*- Co-CEO of KKR. Chm, First Data. Boards: Claremont McKenna Coll

vs. Rumsfeld. *Terry Kawaja *- CEO, Luma Partners. *Juliette Kayyem*- Foreign Affairs Columnist, Boston Globe. Lecturer in Public Policy, Harvard. Asst Sec. for Intergovernmental Affairs, U.S. Dept. of Homeland Security. *Jeff Kearl'- Chm, SkullCandy. *Peter Kellner*-- MD, Richmond Management. Cofound

Carnegie Mellon.Boards: Quantpoint, BioMatricore, BitArmor, Children's Institute, IIT Foundation, Mellon-Pitt Corp. *Charlie Kim*— CEO, NextJump. *David Kirkpatrick*— Author, /The Faccbook Effect/. Fmr head technology writer, FORTUNE. *Henry Kravis*— Co-CEO of KKR. Chm, First Data. Boards: Claremont McKenna Coll

s. Rumsfeld. *Terry Kawaja *— CEO, Luma Partners. *Juliette ICayyem*— Foreign Affairs Columnist, Boston Globe. Lecturer in Public Policy, Harvard. Asst Sec. for Intergovernmental Affairs, U.S. Dept. of Homeland Security. EFTA_R1_00480085 EFTA01974887 *Jeff Kearl'— Chm, SkullCandy. *Peter Kellner*--

Carnegie Mellon.Boards: Quantpoint, BioMatricore, BitArmor, Children's Institute, lIT Foundation, Mellon-Pitt Corp. *Charlie Kim*— CEO, NextJump. *David Kirkpatrick*— Author, /The Facebook Effect/. Fmr head technology writer, FORTUNE. *Henry Kravis"- Co-CEO of KKR. Chm, First Data. Boards: Claremont McKenna Coll

vs. Rumsfeld. *Terry Kawaja *— CEO, Luma Partners. *Juliette Kayyem*— Foreign Affairs Columnist, Boston Globe. Lecturer in Public Policy, Harvard. Asst Sec. for Intergovernmental Affairs, U.S. Dept. of Homeland Security. *Jeff Kearl*— Chm, SkullCandy. *Peter Kellner*-- MD, Richmond Management. Cofounde

Carnegie Mellon.Boards: Quantpoint, BioMatricore, BitArmor, Children's Institute, IIT Foundation, Mellon-Pitt Corp. •Charlie Kim*— CEO, NextJump. •David Kirkpatrick•— Author, /The Facebook Effect/. Fmr head technology writer, FORTUNE. •Henry Kravis•— Co-CEO of KKR. Chm, First Data. Boards: Claremont McKenna Colle

an vs. Rumsfeld. •Terry Kawaja CEO, Luma Partners. •Juliette Kayyem•— Foreign Affairs Columnist, Boston Globe. Lecturer in Public Policy, Harvard. Asst Sec. for Intergovernmental Affairs, U.S. Dept. of Homeland Security. •Jeff Kearl.— Chm, SkullCandy. •Peter Kellner•-- MD, Richmond Management. Cofoun

Carnegie Mellon.Boards: Quantpoint, BioMatricore, BitArmor, Children's Institute, IIT Foundation, Mellon-Pitt Corp. •Charlie Kim*— CEO, NextJump. •David Kirkpatrick•— Author, /The Facebook Effect/. Fmr head technology writer, FORTUNE. •Henry Kravis•— Co-CEO of KKR. Chm, First Data. Boards: Claremont McKenna Colle

an vs. Rumsfeld. •Terry Kawaja CEO, Luma Partners. •Juliette Kayyem•— Foreign Affairs Columnist, Boston Globe. Lecturer in Public Policy, Harvard. Asst Sec. for Intergovernmental Affairs, U.S. Dept. of Homeland Security. •Jeff Kearl.— Chm, SkullCandy. •Peter Kellner•-- MD, Richmond Management. Cofoun